Certara to Participate in Upcoming Investor Conferences
RADNOR, Pa., May 18, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader…
CertaraMay 18, 2026
GlobalSubmit™ PUBLISH: Simplifying Global eCTD Submissions from One Platform
Explore GlobalSubmit PUBLISH for global eCTD publishing and submissions across FDA, EMA, Health Canada, PMDA,…
CertaraMay 18, 2026
FDA Rebuilding After DOGE Cuts: Former Regulators Speak Out
Former FDA officials describe the impact of DOGE-era staffing cuts, lost expertise, and the challenges…
CertaraMay 15, 2026
How to Leverage PBPK Modeling and Simulation in Drug Research and Development
Learn how PBPK modeling and simulation in drug research and development reduces clinical burden, supports…
CertaraMay 12, 2026
Predicting FcRn-Mediated PK/PD with PBPK Modeling
Learn how PBPK modeling predicts FcRn binder PK/PD and IgG dynamics across species.
CertaraMay 12, 2026
Predicting Ocular Drug Behavior with PBPK Modeling
Learn how PBPK modeling predicts ocular drug exposure and target occupancy to optimize anti-VEGF therapies…
CertaraMay 12, 2026
Advancing In Vivo CAR-T with QSP
Learn how QSP modeling improves first-in-human dose selection for CAR-T therapies, enabling better translation and…
CertaraMay 12, 2026
Certara IQ™ Demo
Watch a short demo of Certara IQ™, a QSP platform for modeling, simulation, and analysis.…
CertaraMay 12, 2026
